News All news Engineering cleantech medtech Software mobility Events Startups fintech news Biotech Science & Education Image news September 4th, 2025 Swiss start-up of the year 2025: Corintis cools the future of computing Most popular Month Year Image medtech Say goodbye to needles for blood glucose monitoring Image medtech New PCR test device from ETH Zurich spin-off in the starting blocks Image news Swiss impact in the global AI renaissance Image medtech Innovations in wound healing: from good bacteria to mechanical reprogramming of tissue Image medtech Say goodbye to needles for blood glucose monitoring Image medtech New PCR test device from ETH Zurich spin-off in the starting blocks Image news Swiss impact in the global AI renaissance Image medtech Innovations in wound healing: from good bacteria to mechanical reprogramming of tissue Pagination First page First Previous page Page 1 Page 2 Page 3 Current page 4 Partners feed Image 07.05.24 - startupticker.ch Memo Therapeutics raises additional CHF20 million Image 03.05.24 - startupticker.ch USD 6 million to fight a silent epidemic Image 03.05.24 - startupticker.ch Robotic guards touch base in Germany Image 02.05.24 - startupticker.ch Ikerian raises USD 6.18M in Series A Extension Financing round Image 30.04.24 - startupticker.ch Asian markets attract Swiss startups Image 30.04.24 - startupticker.ch Swiss tech startups continue to win accolades worldwide Image 29.04.24 - startupticker.ch EPFL spinoff secures $3.2 Million in seed funding for green hydrogen production Image 23.04.24 - startupticker.ch New report presents good figures from the Swiss biotech sector as high flyers flourish Image 25.04.24 - startupticker.ch Backbone aims for European Leadership with latest acquisition Load More
Image news September 4th, 2025 Swiss start-up of the year 2025: Corintis cools the future of computing
Image 29.04.24 - startupticker.ch EPFL spinoff secures $3.2 Million in seed funding for green hydrogen production
Image 23.04.24 - startupticker.ch New report presents good figures from the Swiss biotech sector as high flyers flourish
